Products within this site have been lab tested by Anresco Laboratories, ISO 17025 accredited (DEA/FDA registered) which contains < 0.3% Delta-9 THC (legal limit) federally legal hemp.
Products within this site have been lab tested by Anresco Laboratories, ISO 17025 accredited (DEA/FDA registered) which contains < 0.3% Delta-9 THC (legal limit) federally legal hemp.
Cart 0
Jack Frost (1 lb/454 g) w/ Certificate of Analysis.
Jack Frost (1 lb/454 g) w/ Certificate of Analysis.
Jack Frost (1 lb/454 g) w/ Certificate of Analysis.
12.96% CBGA ✅

Jack Frost (1 lb/454 g) w/ Certificate of Analysis.

Regular price $499.95 Sale price $599.95 Unit price per
Tax included. Shipping calculated at checkout.

 

Jack Frost CBG Hemp Flower (1 lb/454 g) with Certificate of Analysis.

  • < 0.3% Delta-9 THC (ND - None Detected)
  • 12.96% CBGA ✅
  • Jack Herer X White Widow X Northern Lights #5
  • Indica dominant hybrid
  • Hemp-derived
  • Seedless
  • Outdoor

Bred by Goldenseed, Jack Frost was developed over 5 years of persistence in order to improve on the potency and aroma of this strain. Initially with a lineage of Jack Herer, White Widow, and Northern Lights #5. Rainbow Kashmiri was later introduced in the breeding process.

 

What is CBGA (Cannabigerolic Acid) & what does this cannabinoid do?

CBGA, or cannabigerolic acid, is one of many minor cannabinoids produced by the cannabis plant.

Unsure of what a “cannabinoid” is? These are compounds cannabis produces that interact with a network of receptors in our body, known as the endocannabinoid system.

Performing a protective function for cannabis, CBGA is produced in the plant’s  trichomes and triggers targeted plant cell necrosis for natural leaf pruning to allow the plant to maximize energy directed toward the flower.

CBGA is a foundational compound of the cannabis flower. In fact, you might think of CBGA as the “granddaddy” of cannabinoids. Why? Because CBGA is at the top of the cascade reaction that produces the three major cannabinoid lines:

  • THCA (tetrahydrocannabinolic acid)
  • CBDA (cannabidiolic acid)
  • CBCA (cannabichromenic acid)

These eventually become THC, CBD, or CBC, respectively. CBGA may also convert to CBG, but in a majority of strains, CBGA eventually converts into either THC or CBD.

 

The Discovery of CBGA

Scientists have known about CBG (cannabigerol) for over 50 years. Israeli researchers were the first to isolate the cannabinoid, and 30 years later, Japanese researchers were the first to reveal that CBGA was its precursor. Despite the long history, minimal research has been conducted on CBGA to date.

Most of that CBGA research has focused on sustainable production of THCA for pharmaceutical and research uses. This research specifically has looked at the mechanism of converting CBGA into THCA.

Researchers have demonstrated a consistent way of replicating the cannabinoid in a species of yeast known as Pichia pastoris, one that is widely used for recombinant DNA protein. Research teams have even done computational modeling to optimize production, and in 2019, a California research team published their work on complete synthesis of cannabinoids, including CBGA, from yeast derivatives.

 

Metabolic Disorders

Another research team discovered that CBGA may also help patients with other metabolic disorders. The 2019 in silico study (computer simulation) was performed to look at CBGA’s role in activating peroxisome proliferator activated receptors (PPARs) that regulate metabolism. When PPARs do not function properly, people develop diseases like diabetes and high levels of cholesterol or triglycerides (dyslipidemia). This study showed that CBGA activated the PPAR receptors, stimulating lipid metabolism and thereby reducing excess lipid accumulation. The study needs to be repeated in animal and human trials.

 

Colon Cancer

Finally, CBGA may one day prove crucial for patients with colorectal cancer, the third most common cancer and fourth leading cause of cancer-related death. Researchers looked at cytotoxic effects of CBGA extracted from cannabis, and found that not only did the CBGA kill colon cancer cells, but it hastened early cancer cell death and arrested the cancer cell cycle. While more research is definitely needed, the researchers were encouraged that CBGA may effectively target not only colon cancer cells, but could also prevent the growth and proliferation of polyps. Left untreated, these polyps grow into carcinomas.

 

WATCHARASAKUNEE INVESTMENT GROUP, LLC, is a California based business specializing in the investment and distribution of industrial hemp products in compliance with the 2018 Farm Bill.

While we understand the suspicious nature of the products we distribute, all products within this site have been lab tested by Anresco Laboratories, ISO 17025 accredited (DEA/FDA registered) which contains < 0.3% delta-9 THC (legal limit) federally legal hemp.

To verify claims, please refer to the Certificate of Analysis provided.

10% of sales will be donated to the Wounded Warriors Project.

You must be 18 years of age or older to purchase.

Shipped via United States Postal Service, Priority Mail (3 - 5 business days).

  • Complies with United States Postal Service shipping guidelines
  • Shipped to 49 states (excluding Idaho)
  • Legal documents enclosed
  • Double layered vacuum sealed 
  • Insured for full amount

Domestic ONLY, NO international shipping.

Use code HEMP2020 at checkout for FREE shipping on all orders.

Payment must be received before noon for same day processing. Processing dates are Monday - Saturday. We do not ship on federal holidays.

Please excuse any shipping delays while this pandemic is active.

 

FDA DISCLAIMER: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act require this notice.

Watcharasakunee Investment Group, LLC, makes no representation and assumes no responsibility for the accuracy of information contained on or available through this website, and such information is subject to change without notice. You are encouraged to confirm any information obtained from or through this listing with other sources, and review all information regarding any medical condition or treatment with your physician.

All content, including text, graphics, images and information, contained on or available through this website is for general information purposes only.

(NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH THIS WEBSITE)